Skadden Reps Pfizer In $240M Deal For Teuto Stake
Pfizer Inc. said Wednesday it agreed to buy a 40 percent stake in Laboratorio Teuto Brasileiro SA, a Brazilian generic drugmaker, for R$400 million ($240 million) as the company seeks to...To view the full article, register now.
Already a subscriber? Click here to view full article